Randomised trial of an internet-based evidence-based medicine continuing education intervention

ISRCTN ISRCTN00946598
DOI https://doi.org/10.1186/ISRCTN00946598
Secondary identifying numbers MOP-53096
Submission date
01/09/2005
Registration date
24/02/2006
Last edited
18/04/2008
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Circulatory System
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Not provided at time of registration

Contact information

Dr Sharon Straus
Scientific

Toronto Western Hospital
New East Wing 8-418
399 Bathurst St
Toronto
M5T 2S8
Canada

Phone +1 416 603 5963
Email sstraus@mtsinai.on.ca

Study information

Study designRandomised controlled trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Not specified
Study typeNot Specified
Scientific title
Study objectivesWe anticipate that an internet-based evidence-based medicine (EBM) course that is targeted for specific medication compared to traditional CME will lead to increased use of specific medications.
Ethics approval(s)Health Sciences II Research Ethics Board, University of Toronto, Toronto, Ontario, Canada (5 April, 2002).
Health condition(s) or problem(s) studiedStroke and Diabetes - continuing medical education (CME) study
InterventionGroup 1. Online course on evidence-based medicine where the topic studied is related to stroke. There are ten sessions and we ask the family physician to complete this course within 6 months.
Group 2. Online course on evidence-based medicine where the topic is related to diabetes. There are ten sessions and we ask the family physician to complete the course within 6 months.
Group 3. Mailed materials where there is a practice guideline on stroke and a hard copy of a slide presentation on stroke (traditional CME). We ask the family physician to complete the readings within 6 months.
Intervention typeOther
Primary outcome measureThe proportion of appropriate patients who receive a prescription for statins 12 months after the completion of the study intervention i.e. the online course or completion of readings.
Secondary outcome measures1. The proportion of patients with coronary heart failure (CHF) who receive beta-blockers
2. The proportion of patients with atrial fibrillation who receive prescriptions for warfarin at 6, 12, and 24 months after the study intervention
3. Physician satisfaction with the CME online course and the readings will be evaluated
Overall study start date15/05/2004
Completion date31/03/2007

Eligibility

Participant type(s)Patient
Age groupAdult
Lower age limit18 Years
SexBoth
Target number of participants350
Key inclusion criteria1. In practice for at least one year
2. Will be in practice for the next year
3. Aged greater than or equal to 18 years old, either sex
4. 50% of the clinical practice are adults
5. Access to the internet
6. Able to converse and read in English
Key exclusion criteria1. Cannot speak English
2. Participating in another EBM CME study
3. Retiring from clinical practice witihin one year of the study onset
4. Permission denied for viewing prescription practices
Date of first enrolment15/05/2004
Date of final enrolment31/03/2007

Locations

Countries of recruitment

  • Canada

Study participating centre

Toronto Western Hospital
Toronto
M5T 2S8
Canada

Sponsor information

University of Toronto (Canada)
University/education

27 Kings College Circle
Toronto
M5S 1A1
Canada

ROR logo "ROR" https://ror.org/03dbr7087

Funders

Funder type

Research organisation

Canadian Institutes of Health Research (CIHR) (Canada) - http://www.cihr-irsc.gc.ca (ref: MOP-53096)

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan